Circulating biomarker panels for targeted therapy in brain tumors

Cristiana Tanase1, Radu Albulescu, Elena Codrici

  • 1Victor Babes National Institute of Pathology, Biochemistry-Proteomics Department, no 99-101 Splaiul Independentei, 050096 Sector 5 Bucharest, Romania.

Summary

Developing cancer risk-identifier biomarkers is crucial for early detection and targeted therapy in oncology. This research explores circulating biomarker panels for effective brain tumor monitoring and personalized medicine.